Neumora Therapeutics, Inc. (NMRA)
NASDAQ: NMRA · Real-Time Price · USD
0.6918
-0.0382 (-5.23%)
Sep 21, 2026, 4:00 PM EDT - Market closed
Neumora Therapeutics Market Cap
Neumora Therapeutics has a market cap or net worth of $129.99 million as of September 21, 2026. Its market cap has decreased by -54.39% in one year.
Market Cap
129.99M
Enterprise Value
66.40M
1-Year Change
-54.39%
Ranking
Category
Stock Price
$0.69
ChartMarket Cap Chart
Since the IPO on September 15, 2023, Neumora Therapeutics's market cap has decreased from $2.58B to $129.99M, a decrease of -94.97%. That is a compound annual growth rate of -62.85%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 21, 2026 | 129.99M | -57.27% |
| Dec 31, 2025 | 304.19M | -82.24% |
| Dec 31, 2024 | 1.71B | -34.22% |
| Dec 29, 2023 | 2.60B | 0.79% |
| Sep 15, 2023 | 2.58B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Immunic | 144.90M |
| Corbus Pharmaceuticals Holdings | 144.67M |
| NRx Pharmaceuticals | 143.63M |
| Kazia Therapeutics | 142.38M |
| Conexeu Sciences | 139.91M |
| Caribou Biosciences | 139.37M |
| TuHURA Biosciences | 133.83M |
| Unicycive Therapeutics | 133.71M |